Torrent Pharmaceuticals Ltd.

1775.00 -60.80 ▼-3.3%

01 June 2023, 03:18:59 PM
Volume: 1,031,984

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.torrentpharma.com
Market Cap 60,458.20 Cr.
Enterprise Value(EV) 67,147.18 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 36.79 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 48.56 Trailing Twelve Months Ending 2023-03
Industry PE 31.80 Trailing Twelve Months Ending 2023-03
Book Value / Share 183.14 Trailing Twelve Months Ending 2023-03
Price to Book Value 9.75 Calculated using Price: 1,786.35
Dividend Yield 1.23 Period Ending 2022-03
No. of Shares Subscribed 33.84 Cr. 338,445,440 Shares
FaceValue 5
About Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.

Torrent Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Torrent Pharmaceuticals Ltd. Performance

1 Day
-3.31%
1 Week
+4.33%
1 Month
+7.43%
3 Month
+20.31%
6 Month
+8.12%
1 Year
+26.05%
2 Year
+27.44%
5 Year
+143.99%
10 Year
+800.83%

Torrent Pharmaceuticals Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 39.94 34.19 57.92 23.80 15.12 9.34 21.47 23.49 13.18
Return on Capital Employed (%) 35.06 26.98 45.63 20.36 13.81 9.75 15.28 17.62 14.35
Return on Assets (%) 15.16 11.71 20.89 10.28 5.81 3.15 7.50 9.20 5.92

Torrent Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 1,902 2,491 3,494 4,350 4,622 4,724 4,823 5,837 5,953 6,198
Non Curr. Liab. 927 2,505 1,995 2,303 4,142 3,861 3,299 2,924 2,238 2,823
Curr. Liab. 2,175 2,824 3,285 2,738 5,202 5,165 5,454 4,892 4,415 5,447
Minority Int. 0 0 0 0 1
Equity & Liab. 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 14,468
Non Curr. Assets 1,600 3,768 4,086 4,513 8,705 8,714 8,596 8,130 7,312 9,139
Curr. Assets 3,404 4,051 4,680 4,879 5,262 5,038 4,979 5,522 5,165 5,329
Misc. Exp. not W/O
Total Assets 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 14,468

Torrent Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 4,185 4,653 6,667 5,816 5,950 7,673 7,939 8,005 8,508 9,620
Other Income 38 286 229 223 307 64 121 57 197 45
Total Income 4,223 4,939 6,896 6,039 6,257 7,736 8,061 8,061 8,705 9,665
Total Expenditure -3,233 -3,633 -3,937 -4,438 -4,609 -5,696 -5,769 -5,524 -6,077 -6,778
PBIDT 990 1,306 2,959 1,601 1,648 2,040 2,292 2,537 2,628 2,887
Interest -59 -175 -184 -206 -308 -504 -451 -353 -255 -333
Depreciation -87 -191 -238 -307 -409 -618 -654 -658 -662 -707
Taxation -180 -189 -610 -155 -253 -125 -162 -274 -449 -611
Exceptional Items -194 -357 -485
PAT 664 751 1,733 934 678 436 1,025 1,252 777 1,236
Minority Interest 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 664 751 1,733 934 678 436 1,025 1,252 777 1,236
Adjusted EPS 20 22 51 28 20 13 30 37 23 37

Torrent Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 153 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803
Cash Fr. Inv. -242 -356 -2,162 -838 -787 -4,707 -241 199 -449 -197
Cash Fr. Finan. 20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781
Net Change -68 330 -140 469 29 -395 242 42 -95 -175
Cash & Cash Eqvt 687 955 865 1,050 1,068 702 940 662 573 398

Torrent Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
Public 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Torrent Pharmaceuticals Ltd. Announcements

Wed, 31 May 2023
Press Release
Torrent Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "A Press Release on Financial Results which is being submitted to the media is also enclosed herewith".
Wed, 31 May 2023
Investor Presentation
Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation
Wed, 31 May 2023
Related Party Transactions
Torrent Pharmaceuticals Limited has informed the Exchange about related Party Transactions

Torrent Pharmaceuticals Ltd. Technical Scans

Wed, 31 May 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing 52 Week High Close Crossing 52 Week High
Closing Above Previous High Closing Above Previous High

Torrent Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 234,307.06 987.30 +1.2%
Divi's Laboratories Ltd. 91,634.44 3,525.10 +2.4%
Cipla Ltd. 77,025.36 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. 75,000.82 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. 66,468.77 4,816.05 +4.2%
Mankind Pharma Ltd. 54,409.92 1,396.00 +2.6%
Max Healthcare Institute Ltd. 52,820.81 529.70 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.59 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 50.26 3,525.10 +2.4%
Cipla Ltd. Consolidated 2023-03 27.49 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.63 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 80.93 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 40.75 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2023-03 47.87 529.70 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.18 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7.18 3,525.10 +2.4%
Cipla Ltd. Consolidated 2023-03 3.29 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.22 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 10.71 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 5.24 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2023-03 7.13 529.70 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,525.10 +2.4%
Cipla Ltd. Consolidated 2022-03 0.04 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 529.70 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,525.10 +2.4%
Cipla Ltd. Consolidated 2022-03 13.10 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 529.70 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,525.10 +2.4%
Cipla Ltd. Consolidated 2022-03 13.10 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 529.70 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,525.10 +2.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 529.70 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.30 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,525.10 +2.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 963.30 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,550.95 +1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,816.05 +4.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,396.00 +2.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 529.70 -3.6%

Torrent Pharmaceuticals Ltd. FAQ's

What is Torrent Pharma share price?

Can I buy Torrent Pharma shares now?

What is the Dividend Yield of Torrent Pharma?

What is the Market Cap of Torrent Pharma?

What are the key metrics to analyse Torrent Pharma?

What is the 52 Week High and Low of Torrent Pharma?

What is the trend of Torrent Pharma share price?